MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE

MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE was reported 16226 times

MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POOR QUALITY DEVICE USED 1556 0.1549
1 PRODUCT CONTAINER ISSUE 417 0.0486
2 PRODUCT DELIVERY MECHANISM ISSUE 145 0.0269
3 PRODUCT QUALITY ISSUE 3321 0.0244
4 BREATH ALCOHOL TEST POSITIVE 5 0.0222
5 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 98 0.0180
6 DEVICE MALFUNCTION 1238 0.0176
7 NO ADVERSE EVENT 3122 0.0172
8 PRODUCT DOSAGE FORM ISSUE 8 0.0166
9 PEAK EXPIRATORY FLOW RATE DECREASED 7 0.0159
10 ADRENAL SUPPRESSION 13 0.0154
11 CHRONIC LEFT VENTRICULAR FAILURE 5 0.0139
12 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 466 0.0138
13 ESSENTIAL HYPERTENSION 25 0.0136
14 DRUG DOSE OMISSION 2135 0.0129
15 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 86 0.0120
16 INCORRECT DOSE ADMINISTERED BY PRODUCT 19 0.0119
17 CYSTIC FIBROSIS 60 0.0108
18 INFUSION SITE DISCHARGE 18 0.0103
19 INFUSION SITE PRURITUS 29 0.0092
20 BRONCHIAL SECRETION RETENTION 11 0.0086
21 LUNG HYPERINFLATION 7 0.0081
22 TOTAL LUNG CAPACITY DECREASED 13 0.0081
23 INFUSION SITE BRUISING 17 0.0079
24 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 7 0.0078
25 PRODUCT TASTE ABNORMAL 104 0.0077
26 ASTHMA 858 0.0076
27 HYPERPARATHYROIDISM SECONDARY 19 0.0076
28 NASAL INFLAMMATION 8 0.0076
29 PULMONARY FUNCTION TEST DECREASED 33 0.0075
30 BLOOD IMMUNOGLOBULIN E INCREASED 18 0.0074
31 RESPIRATION ABNORMAL 51 0.0074
32 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 343 0.0073
33 POOR QUALITY DRUG ADMINISTERED 46 0.0071
34 IMPAIRED QUALITY OF LIFE 102 0.0071
35 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
36 CANDIDA INFECTION 119 0.0070
37 BRONCHIAL WALL THICKENING 5 0.0070
38 WHEEZING 402 0.0068
39 INFUSION SITE WARMTH 8 0.0065
40 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 6 0.0065
41 INFUSION SITE HAEMORRHAGE 21 0.0064
42 PRODUCT LOT NUMBER ISSUE 14 0.0063
43 CONJUNCTIVITIS ALLERGIC 9 0.0061
44 SINUS OPERATION 14 0.0059
45 PULMONARY PAIN 17 0.0058
46 CHRONIC RESPIRATORY FAILURE 7 0.0058
47 PHARYNGEAL INFLAMMATION 7 0.0058
48 RESPIRATORY TRACT IRRITATION 6 0.0057
49 INFUSION SITE SWELLING 36 0.0057
50 REBOUND ACID HYPERSECRETION 17 0.0056
51 MULTIPLE ALLERGIES 44 0.0056
52 NEPHROGENIC ANAEMIA 26 0.0056
53 PRODUCT DOSE OMISSION 365 0.0056
54 CERUMEN IMPACTION 5 0.0055
55 LOWER RESPIRATORY TRACT CONGESTION 9 0.0053
56 PRE-EXISTING CONDITION IMPROVED 33 0.0053
57 ACUTE SINUSITIS 9 0.0052
58 BODY MASS INDEX INCREASED 7 0.0052
59 ANIMAL SCRATCH 5 0.0051
60 EXPIRED DEVICE USED 17 0.0051
61 POOR QUALITY PRODUCT ADMINISTERED 54 0.0051
62 NASAL DISCHARGE DISCOLOURATION 7 0.0051
63 CATAPLEXY 7 0.0049
64 APHONIA 69 0.0049
65 DYSPHONIA 286 0.0049
66 NOROVIRUS INFECTION 7 0.0048
67 BONE DEMINERALISATION 5 0.0047
68 PHARYNGEAL ERYTHEMA 10 0.0047
69 INCORRECT DOSAGE ADMINISTERED 23 0.0047
70 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 235 0.0045
71 ORAL CANDIDIASIS 58 0.0044
72 RHINITIS ALLERGIC 19 0.0043
73 OXYGEN THERAPY 7 0.0043
74 SEASONAL ALLERGY 60 0.0042
75 AUDITORY DISORDER 6 0.0042
76 SPUTUM INCREASED 9 0.0042
77 INFUSION SITE ERYTHEMA 35 0.0041
78 RHINOVIRUS INFECTION 16 0.0041
79 NASAL SEPTUM DEVIATION 8 0.0041
80 SHOULDER ARTHROPLASTY 11 0.0041
81 VOCAL CORD DISORDER 8 0.0041
82 DEVICE INFUSION ISSUE 10 0.0040
83 UNDERDOSE 294 0.0040
84 DEVICE DEPOSIT ISSUE 8 0.0039
85 PNEUMONIA PSEUDOMONAL 6 0.0039
86 ORAL MUCOSAL ERUPTION 6 0.0039
87 RESPIRATORY TRACT CONGESTION 62 0.0039
88 INTENTIONAL DEVICE MISUSE 17 0.0039
89 BRONCHITIS CHRONIC 9 0.0037
90 PRODUCT AVAILABILITY ISSUE 83 0.0036
91 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
92 BRONCHIECTASIS 24 0.0036
93 UPPER-AIRWAY COUGH SYNDROME 29 0.0035
94 PHARYNGEAL DISORDER 10 0.0035
95 EXPIRED PRODUCT ADMINISTERED 115 0.0035
96 PARANASAL SINUS DISCOMFORT 13 0.0034
97 PHARYNGITIS STREPTOCOCCAL 37 0.0034
98 INFUSION SITE PAIN 44 0.0034
99 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 8 0.0034
100 SINUSITIS 342 0.0033
101 BRONCHITIS 247 0.0033
102 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20 0.0033
103 PRODUCT DISPENSING ISSUE 14 0.0033
104 OESOPHAGEAL SPASM 6 0.0033
105 COUGH 913 0.0033
106 FEELING JITTERY 62 0.0033
107 NASAL POLYPS 16 0.0032
108 INCORRECT DOSE ADMINISTERED BY DEVICE 85 0.0032
109 DIASTOLIC DYSFUNCTION 10 0.0032
110 HORDEOLUM 14 0.0032
111 BRONCHIAL DISORDER 5 0.0032
112 PRODUCTIVE COUGH 153 0.0032
113 DYSPNOEA 1794 0.0032
114 PRODUCT CONTAMINATION PHYSICAL 8 0.0031
115 NECK INJURY 9 0.0031
116 GROWTH RETARDATION 9 0.0031
117 ANIMAL BITE 8 0.0030
118 SINUS PAIN 7 0.0030
119 RESPIRATORY TRACT INFECTION 78 0.0030
120 PRODUCT USE ISSUE 562 0.0030
121 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0030
122 VITAMIN D DEFICIENCY 29 0.0030
123 PRODUCT ODOUR ABNORMAL 31 0.0030
124 SECRETION DISCHARGE 37 0.0030
125 CHRONIC SINUSITIS 11 0.0029
126 PARANASAL SINUS HYPERSECRETION 11 0.0029
127 CHEST DISCOMFORT 293 0.0029
128 SLEEP APNOEA SYNDROME 54 0.0028
129 UPPER RESPIRATORY TRACT INFECTION 130 0.0028
130 AORTIC VALVE STENOSIS 5 0.0028
131 PRODUCT LABEL ISSUE 19 0.0028
132 EXERCISE TOLERANCE DECREASED 16 0.0028
133 LUNG INFECTION 43 0.0028
134 OBSTRUCTION 11 0.0028
135 CANCER PAIN 7 0.0027
136 DRUG ADMINISTRATION ERROR 84 0.0027
137 BIPOLAR I DISORDER 6 0.0027
138 RHINITIS 22 0.0027
139 INCREASED UPPER AIRWAY SECRETION 14 0.0027
140 NASAL CONGESTION 160 0.0027
141 INSURANCE ISSUE 41 0.0027
142 INCORRECT DOSE ADMINISTERED 609 0.0027
143 PAROSMIA 20 0.0026
144 SNORING 10 0.0026
145 PERIARTHRITIS 6 0.0026
146 END STAGE RENAL DISEASE 48 0.0026
147 PRODUCT CLEANING INADEQUATE 7 0.0026
148 PRODUCT DOSE OMISSION ISSUE 769 0.0026
149 ORAL PRURITUS 6 0.0026
150 ADRENAL DISORDER 5 0.0026
151 HYPOPNOEA 9 0.0026
152 PULMONARY CONGESTION 34 0.0026
153 ABDOMINAL WALL HAEMATOMA 5 0.0026
154 PRODUCT PACKAGING ISSUE 24 0.0025
155 OXYGEN CONSUMPTION INCREASED 6 0.0025
156 PNEUMONIA VIRAL 8 0.0025
157 OESOPHAGEAL CANDIDIASIS 10 0.0025
158 WEIGHT ABNORMAL 6 0.0025
159 SNEEZING 56 0.0025
160 EMPHYSEMA 25 0.0025
161 RESPIRATORY SYMPTOM 7 0.0025
162 HEREDITARY ANGIOEDEMA 26 0.0024
163 SINUS DISORDER 47 0.0024
164 CHOKING SENSATION 13 0.0024
165 SINUS HEADACHE 14 0.0024
166 INCORRECT DRUG ADMINISTRATION RATE 10 0.0023
167 ATYPICAL PNEUMONIA 7 0.0023
168 CATHETER SITE PAIN 6 0.0023
169 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 163 0.0023
170 TONGUE DISCOLOURATION 10 0.0023
171 OROPHARYNGEAL PAIN 211 0.0023
172 CHRONIC KIDNEY DISEASE 172 0.0023
173 BRONCHOSPASM 32 0.0022
174 SKIN DISCOMFORT 6 0.0022
175 OROPHARYNGEAL DISCOMFORT 20 0.0022
176 MIGRAINE WITH AURA 6 0.0022
177 ORAL FUNGAL INFECTION 6 0.0022
178 RESPIRATORY SYNCYTIAL VIRUS INFECTION 19 0.0022
179 SPINAL STENOSIS 9 0.0022
180 WRONG TECHNIQUE IN DRUG USAGE PROCESS 78 0.0021
181 THROAT IRRITATION 96 0.0021
182 INFUSION SITE EXTRAVASATION 13 0.0021
183 RESPIRATORY DISORDER 62 0.0021
184 DYSPNOEA EXERTIONAL 78 0.0021
185 PRODUCT DISTRIBUTION ISSUE 19 0.0020
186 EXPIRED DRUG ADMINISTERED 10 0.0020
187 PRODUCT PRESCRIBING ISSUE 44 0.0020
188 SPUTUM DISCOLOURED 19 0.0020
189 BODY HEIGHT DECREASED 21 0.0020
190 FOOD ALLERGY 15 0.0019
191 TONGUE DISORDER 14 0.0019
192 DERMATITIS CONTACT 22 0.0019
193 MIDDLE INSOMNIA 36 0.0019
194 SINUS CONGESTION 26 0.0019
195 VIRAL INFECTION 64 0.0019
196 INABILITY TO AFFORD MEDICATION 19 0.0019
197 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 385 0.0019
198 TONGUE DISCOMFORT 8 0.0019
199 CUSHINGOID 6 0.0019
200 BLOOD SODIUM INCREASED 5 0.0019
201 EAR DISCOMFORT 19 0.0018
202 DEVICE DEFECTIVE 32 0.0018
203 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
204 PULMONARY HYPERTENSION 38 0.0018
205 WEIGHT FLUCTUATION 19 0.0018
206 OXYGEN SATURATION DECREASED 102 0.0018
207 ORAL INFECTION 7 0.0018
208 DRY THROAT 18 0.0018
209 ACUTE RESPIRATORY FAILURE 34 0.0018
210 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 30 0.0018
211 NASAL DISCOMFORT 14 0.0018
212 RHINORRHOEA 114 0.0018
213 VASCULAR DEVICE INFECTION 8 0.0018
214 DECREASED ACTIVITY 19 0.0018
215 WOUND COMPLICATION 6 0.0017
216 MUSCULOSKELETAL CHEST PAIN 27 0.0017
217 PNEUMONIA BACTERIAL 16 0.0017
218 ENURESIS 7 0.0017
219 ADRENAL INSUFFICIENCY 21 0.0017
220 POLYMENORRHOEA 6 0.0017
221 LIGAMENT SPRAIN 17 0.0017
222 CARPAL TUNNEL SYNDROME 24 0.0017
223 INFLUENZA 190 0.0017
224 HYPERURICAEMIA 7 0.0017
225 GLOSSITIS 6 0.0017
226 PLEURISY 10 0.0017
227 SKIN WEEPING 6 0.0017
228 FOOD POISONING 9 0.0017
229 CONCUSSION 13 0.0017
230 ENDOMETRIOSIS 8 0.0017
231 HYPERLIPIDAEMIA 20 0.0017
232 POOR QUALITY SLEEP 36 0.0017
233 THROAT TIGHTNESS 45 0.0017
234 GASTROENTERITIS VIRAL 30 0.0017
235 HUMERUS FRACTURE 8 0.0017
236 EAR INFECTION 44 0.0017
237 CHOKING 32 0.0016
238 SHOULDER OPERATION 7 0.0016
239 PHARYNGEAL SWELLING 16 0.0016
240 LUNG DISORDER 80 0.0016
241 CHEST X-RAY ABNORMAL 5 0.0016
242 BREATH SOUNDS ABNORMAL 8 0.0016
243 HYPERVOLAEMIA 8 0.0016
244 MUSCLE STRAIN 14 0.0016
245 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
246 DRUG PRESCRIBING ERROR 31 0.0016
247 PRODUCT LEAKAGE 9 0.0016
248 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 14 0.0016
249 CATHETERISATION CARDIAC 7 0.0016
250 PNEUMONIA 510 0.0016
251 RIGHT VENTRICULAR FAILURE 11 0.0016
252 NERVOUSNESS 82 0.0016
253 THYROID MASS 6 0.0016
254 MOUTH SWELLING 9 0.0016
255 HIATUS HERNIA 20 0.0015
256 PULMONARY MASS 23 0.0015
257 URINE ABNORMALITY 7 0.0015
258 INCORRECT ROUTE OF DRUG ADMINISTRATION 55 0.0015
259 CHEST PAIN 284 0.0015
260 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
261 BREAST ENLARGEMENT 5 0.0015
262 SKIN ODOUR ABNORMAL 6 0.0015
263 DYSGRAPHIA 10 0.0015
264 CATARACT OPERATION 9 0.0015
265 HAEMOPTYSIS 42 0.0015
266 EYE INFECTION 17 0.0015
267 PHARYNGEAL OEDEMA 23 0.0015
268 LACERATION 14 0.0015
269 ADVERSE EVENT 137 0.0015
270 FRUSTRATION TOLERANCE DECREASED 12 0.0015
271 VITAMIN B12 DEFICIENCY 6 0.0015
272 GASTROOESOPHAGEAL REFLUX DISEASE 119 0.0015
273 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
274 BACK INJURY 16 0.0015
275 PRODUCT DISPENSING ERROR 32 0.0015
276 INTENTIONAL PRODUCT MISUSE 128 0.0015
277 CATARACT 87 0.0015
278 ECONOMIC PROBLEM 22 0.0015
279 EYE DISCHARGE 15 0.0014
280 FIBROMYALGIA 35 0.0014
281 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69 0.0014
282 ANAPHYLACTIC REACTION 79 0.0014
283 EYE PRURITUS 48 0.0014
284 OCULAR DISCOMFORT 16 0.0014
285 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
286 DEVICE DELIVERY SYSTEM ISSUE 39 0.0014
287 NASOPHARYNGITIS 261 0.0014
288 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
289 NERVE COMPRESSION 13 0.0014
290 TENSION HEADACHE 6 0.0014
291 IMPAIRED GASTRIC EMPTYING 19 0.0014
292 HYPOXIA 49 0.0014
293 MIGRAINE 132 0.0014
294 SKIN SWELLING 12 0.0014
295 HYPERVENTILATION 8 0.0014
296 DEVICE FAILURE 21 0.0014
297 SWOLLEN TONGUE 43 0.0014
298 OESOPHAGITIS 15 0.0014
299 HAEMORRHAGIC ANAEMIA 6 0.0014
300 PHYSICAL DISABILITY 6 0.0014
301 ANKLE FRACTURE 21 0.0014
302 PRODUCT USE IN UNAPPROVED INDICATION 336 0.0014
303 ORAL PAIN 30 0.0013
304 GASTROINTESTINAL INFECTION 12 0.0013
305 EAR PAIN 26 0.0013
306 PNEUMOTHORAX 21 0.0013
307 FULL BLOOD COUNT ABNORMAL 14 0.0013
308 DRUG EFFECT DELAYED 6 0.0013
309 FOOT FRACTURE 25 0.0013
310 HOSPICE CARE 13 0.0013
311 CHOLECYSTECTOMY 15 0.0013
312 RENAL INJURY 39 0.0013
313 EAR DISORDER 6 0.0013
314 DYSGEUSIA 97 0.0013
315 OVERWEIGHT 7 0.0013
316 LARGE INTESTINE POLYP 9 0.0013
317 HEAD DISCOMFORT 23 0.0013
318 LARYNGEAL OEDEMA 8 0.0013
319 COVID-19 227 0.0013
320 THERAPEUTIC RESPONSE UNEXPECTED 58 0.0013
321 ROSACEA 6 0.0013
322 UMBILICAL HERNIA 6 0.0013
323 PSEUDOMONAS INFECTION 11 0.0013
324 HEART RATE INCREASED 127 0.0013
325 GOUT 23 0.0013
326 ORAL HERPES 25 0.0013
327 NASAL DRYNESS 8 0.0013
328 INJECTION SITE RASH 39 0.0013
329 DRY MOUTH 103 0.0013
330 NEPHROLITHIASIS 58 0.0013
331 OBESITY 20 0.0013
332 HEART RATE ABNORMAL 7 0.0013
333 UPPER LIMB FRACTURE 25 0.0013
334 DERMATITIS ATOPIC 66 0.0013
335 ROTATOR CUFF SYNDROME 16 0.0012
336 ANOSMIA 18 0.0012
337 HEART RATE IRREGULAR 28 0.0012
338 BLOOD POTASSIUM DECREASED 37 0.0012
339 ORAL DISCOMFORT 17 0.0012
340 ILLNESS 126 0.0012
341 SOMNAMBULISM 8 0.0012
342 ANHEDONIA 32 0.0012
343 TOOTH INFECTION 16 0.0012
344 DIABETIC NEUROPATHY 6 0.0012
345 BLOOD PRESSURE ABNORMAL 24 0.0012
346 PRODUCT USE COMPLAINT 19 0.0012
347 ELECTROLYTE IMBALANCE 14 0.0012
348 INCREASED TENDENCY TO BRUISE 11 0.0012
349 SKIN LACERATION 13 0.0012
350 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
351 IRON DEFICIENCY ANAEMIA 11 0.0012
352 OSTEOPOROSIS 49 0.0012
353 CONJUNCTIVITIS 22 0.0012
354 INJECTION SITE URTICARIA 29 0.0012
355 PARAESTHESIA ORAL 17 0.0012
356 TOOTH ABSCESS 12 0.0012
357 LIMB INJURY 32 0.0012
358 ODYNOPHAGIA 7 0.0012
359 PERIPHERAL VASCULAR DISORDER 6 0.0012
360 CARDIAC OPERATION 10 0.0012
361 TENDONITIS 18 0.0012
362 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
363 FLUID RETENTION 59 0.0012
364 LACRIMATION INCREASED 35 0.0012
365 PELVIC FRACTURE 9 0.0012
366 DIVERTICULITIS 32 0.0012
367 MUSCLE SPASMS 211 0.0011
368 RASH PRURITIC 62 0.0011
369 IMPAIRED DRIVING ABILITY 13 0.0011
370 SCAB 13 0.0011
371 BLOOD LACTIC ACID INCREASED 6 0.0011
372 COLD SWEAT 20 0.0011
373 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
374 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
375 TRICUSPID VALVE INCOMPETENCE 9 0.0011
376 PALPITATIONS 132 0.0011
377 RETCHING 24 0.0011
378 BACTERIAL INFECTION 21 0.0011
379 AGEUSIA 28 0.0011
380 KIDNEY INFECTION 22 0.0011
381 OSTEOPENIA 17 0.0011
382 COMPRESSION FRACTURE 6 0.0011
383 RIB FRACTURE 23 0.0011
384 QUALITY OF LIFE DECREASED 15 0.0011
385 FUNGAL INFECTION 37 0.0011
386 TREMOR 184 0.0011
387 PERIPHERAL SWELLING 170 0.0011
388 PULMONARY THROMBOSIS 12 0.0011
389 SPINAL FRACTURE 22 0.0011
390 ABDOMINAL HERNIA 5 0.0011
391 ASPIRATION 12 0.0011
392 EXOSTOSIS 10 0.0011
393 HAIR DISORDER 9 0.0011
394 STAPHYLOCOCCAL INFECTION 36 0.0011
395 TOOTH FRACTURE 12 0.0011
396 DISCOMFORT 66 0.0011
397 SLUGGISHNESS 11 0.0011
398 HERPES SIMPLEX 7 0.0011
399 THINKING ABNORMAL 20 0.0011
400 GLOSSODYNIA 24 0.0011
401 POLYP 7 0.0011
402 HYPERSENSITIVITY 198 0.0011
403 EYE DISORDER 35 0.0011
404 GASTRITIS 28 0.0011
405 PHOTOPHOBIA 20 0.0011
406 POOR VENOUS ACCESS 11 0.0011
407 DRY EYE 53 0.0011
408 SWELLING FACE 69 0.0011
409 ANXIETY 301 0.0011
410 URTICARIA 177 0.0011
411 TENDERNESS 11 0.0011
412 SPINAL OPERATION 13 0.0011
413 VITAMIN D DECREASED 9 0.0011
414 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
415 CARDIAC FAILURE ACUTE 7 0.0010
416 CONTUSION 101 0.0010
417 DRUG EFFECT INCOMPLETE 38 0.0010
418 POST-TRAUMATIC STRESS DISORDER 7 0.0010
419 BLOOD MAGNESIUM DECREASED 9 0.0010
420 PANIC ATTACK 38 0.0010
421 SKIN ATROPHY 6 0.0010
422 HYSTERECTOMY 9 0.0010
423 GLAUCOMA 20 0.0010
424 ATELECTASIS 10 0.0010
425 OCULAR HYPERAEMIA 49 0.0010
426 JOINT INJURY 22 0.0010
427 RASH PAPULAR 23 0.0010
428 AUTOIMMUNE DISORDER 10 0.0010
429 INFECTION 147 0.0010
430 CELLULITIS 51 0.0010
431 DISABILITY 20 0.0010
432 POLLAKIURIA 42 0.0010
433 ACCIDENT 12 0.0010
434 UNEVALUABLE EVENT 76 0.0010
435 WOUND INFECTION 11 0.0010
436 EPISTAXIS 75 0.0010
437 WRIST FRACTURE 12 0.0010
438 HEADACHE 627 0.0010
439 TYPE 1 DIABETES MELLITUS 6 0.0010
440 EYE SWELLING 37 0.0010
441 EYE PAIN 56 0.0010
442 FOOT DEFORMITY 11 0.0010
443 NERVE INJURY 11 0.0010
444 PAIN IN JAW 28 0.0010
445 INGUINAL HERNIA 6 0.0010
446 BLOOD POTASSIUM INCREASED 16 0.0010
447 DIVERTICULUM 7 0.0010
448 BACK DISORDER 16 0.0010
449 INTENTIONAL DOSE OMISSION 28 0.0010
450 IRRITABLE BOWEL SYNDROME 21 0.0010
451 HICCUPS 8 0.0010
452 SKIN FISSURES 19 0.0010
453 RENAL FAILURE 129 0.0010
454 PHARYNGITIS 12 0.0010
455 MENSTRUAL DISORDER 8 0.0010
456 TOOTH LOSS 20 0.0010
457 EOSINOPHIL COUNT INCREASED 8 0.0010
458 MAJOR DEPRESSION 7 0.0010
459 FEELING ABNORMAL 229 0.0010
460 ORAL DISORDER 7 0.0010
461 SENSITIVE SKIN 7 0.0009
462 HEAD INJURY 30 0.0009
463 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
464 DEPRESSION 215 0.0009
465 ARTHROPOD BITE 7 0.0009
466 MALAISE 414 0.0009
467 RESPIRATORY DISTRESS 26 0.0009
468 FOREIGN BODY SENSATION IN EYES 6 0.0009
469 THERAPEUTIC RESPONSE DECREASED 57 0.0009
470 IMMUNODEFICIENCY 14 0.0009
471 CARDIAC FLUTTER 6 0.0009
472 BLOOD IRON DECREASED 11 0.0009
473 URINARY TRACT INFECTION 158 0.0009
474 BONE DENSITY DECREASED 29 0.0009
475 ATRIAL FIBRILLATION 90 0.0009
476 CHEILITIS 5 0.0009
477 DIPLOPIA 24 0.0009
478 BLOOD PRESSURE INCREASED 141 0.0009
479 CARDIAC FAILURE CONGESTIVE 74 0.0009
480 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 166 0.0009
481 VERTIGO 56 0.0009
482 DRUG DISPENSING ERROR 14 0.0009
483 KNEE OPERATION 9 0.0009
484 ACUTE KIDNEY INJURY 140 0.0009
485 NECK PAIN 51 0.0009
486 DRUG EFFECT DECREASED 49 0.0009
487 DEVICE INFORMATION OUTPUT ISSUE 7 0.0009
488 INSOMNIA 239 0.0009
489 GALLBLADDER DISORDER 16 0.0009
490 DIZZINESS 447 0.0009
491 FACIAL PAIN 8 0.0009
492 PULMONARY HAEMORRHAGE 7 0.0009
493 BREAST MASS 6 0.0009
494 PRODUCT PHYSICAL ISSUE 18 0.0009
495 SKIN INFECTION 10 0.0009
496 TYPE 2 DIABETES MELLITUS 30 0.0009
497 INCREASED APPETITE 17 0.0009
498 EXPOSURE VIA SKIN CONTACT 23 0.0009
499 LOWER LIMB FRACTURE 17 0.0009
500 TOOTH EXTRACTION 11 0.0009
501 FURUNCLE 7 0.0009
502 BLOOD ALBUMIN DECREASED 7 0.0009
503 PRODUCT PRESCRIBING ERROR 21 0.0009
504 ABNORMAL LOSS OF WEIGHT 6 0.0009
505 HERNIA 17 0.0009
506 EUPHORIC MOOD 9 0.0009
507 SLEEP DISORDER 62 0.0009
508 ABSCESS 14 0.0009
509 ATRIAL FLUTTER 7 0.0009
510 INITIAL INSOMNIA 9 0.0009
511 SKIN HAEMORRHAGE 13 0.0009
512 MEMORY IMPAIRMENT 120 0.0009
513 HYPERSOMNIA 25 0.0009
514 HYPOAESTHESIA ORAL 13 0.0009
515 MADAROSIS 10 0.0009
516 LOCAL SWELLING 15 0.0009
517 KNEE ARTHROPLASTY 18 0.0009
518 WEIGHT INCREASED 191 0.0009
519 SURGERY 50 0.0009
520 TINNITUS 39 0.0008
521 INJECTION SITE SWELLING 65 0.0008
522 BACK PAIN 197 0.0008
523 FATIGUE 658 0.0008
524 BACTERAEMIA 10 0.0008
525 ECZEMA 44 0.0008
526 PRODUCT SUPPLY ISSUE 6 0.0008
527 SPEECH DISORDER 44 0.0008
528 HOSPITALISATION 129 0.0008
529 THIRST 15 0.0008
530 GAIT INABILITY 28 0.0008
531 INCORRECT PRODUCT STORAGE 11 0.0008
532 HERPES ZOSTER 48 0.0008
533 IMMUNE SYSTEM DISORDER 11 0.0008
534 SWELLING 78 0.0008
535 PRURITUS GENERALISED 18 0.0008
536 PANIC REACTION 6 0.0008
537 HYPERCHOLESTEROLAEMIA 8 0.0008
538 PRODUCT PREPARATION ERROR 17 0.0008
539 LOCALISED INFECTION 20 0.0008
540 DIZZINESS POSTURAL 8 0.0008
541 RESTLESS LEGS SYNDROME 15 0.0008
542 NOCTURIA 10 0.0008
543 DYSPEPSIA 81 0.0008
544 NEURALGIA 20 0.0008
545 HAIR TEXTURE ABNORMAL 11 0.0008
546 BLOOD GLUCOSE FLUCTUATION 9 0.0008
547 HAEMORRHOIDS 16 0.0008
548 CHILLS 96 0.0008
549 GASTROINTESTINAL PAIN 9 0.0008
550 SCAR 14 0.0008
551 MOOD SWINGS 26 0.0008
552 PAIN IN EXTREMITY 240 0.0008
553 VITREOUS FLOATERS 8 0.0008
554 MUSCULOSKELETAL DISCOMFORT 14 0.0008
555 CEREBRAL DISORDER 6 0.0008
556 PSYCHOLOGICAL TRAUMA 7 0.0008
557 FEELING DRUNK 6 0.0008
558 HAIR COLOUR CHANGES 10 0.0008
559 LUNG NEOPLASM MALIGNANT 33 0.0008
560 URINE OUTPUT DECREASED 7 0.0008
561 GENERAL SYMPTOM 6 0.0008
562 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
563 OVARIAN CYST 8 0.0008
564 NAIL DISORDER 7 0.0008
565 EYE IRRITATION 46 0.0008
566 ANGER 27 0.0008
567 RASH 348 0.0008
568 OEDEMA PERIPHERAL 97 0.0008
569 DEPRESSED MOOD 42 0.0008
570 LIVER FUNCTION TEST INCREASED 17 0.0008
571 VISION BLURRED 108 0.0008
572 PULMONARY FIBROSIS 15 0.0008
573 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
574 OSTEOARTHRITIS 33 0.0008
575 ATRIOVENTRICULAR BLOCK 6 0.0008
576 TOOTHACHE 14 0.0008
577 BLOOD CHOLESTEROL INCREASED 36 0.0008
578 ARTHRALGIA 320 0.0008
579 CONDITION AGGRAVATED 234 0.0008
580 TREATMENT NONCOMPLIANCE 42 0.0008
581 HYPOACUSIS 33 0.0008
582 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
583 DERMATITIS 16 0.0008
584 DYSURIA 28 0.0008
585 INJECTION SITE DISCOMFORT 8 0.0008
586 UROSEPSIS 7 0.0008
587 FALL 252 0.0008
588 MEDICATION ERROR 42 0.0008
589 BLOOD PRESSURE DECREASED 50 0.0008
590 EATING DISORDER 16 0.0008
591 IMPAIRED WORK ABILITY 16 0.0007
592 PRURITUS 287 0.0007
593 THROMBOSIS 60 0.0007
594 BURSITIS 9 0.0007
595 MUSCLE TIGHTNESS 12 0.0007
596 ABDOMINAL PAIN UPPER 152 0.0007
597 POST PROCEDURAL INFECTION 6 0.0007
598 ARTHRITIS 58 0.0007
599 LYMPHADENOPATHY 26 0.0007
600 TACHYCARDIA 65 0.0007
601 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
602 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
603 VISUAL IMPAIRMENT 90 0.0007
604 INFUSION RELATED REACTION 48 0.0007
605 DENTAL CARIES 8 0.0007
606 NIGHTMARE 25 0.0007
607 HYPERTENSION 153 0.0007
608 TOOTH DISORDER 16 0.0007
609 OEDEMA 39 0.0007
610 SKIN DISCOLOURATION 33 0.0007
611 DYSPHAGIA 68 0.0007
612 EXTRA DOSE ADMINISTERED 29 0.0007
613 NIGHT SWEATS 23 0.0007
614 RENAL TUBULAR NECROSIS 7 0.0007
615 RESPIRATORY FAILURE 52 0.0007
616 MUSCULAR WEAKNESS 81 0.0007
617 SENSATION OF FOREIGN BODY 6 0.0007
618 THERAPY CHANGE 7 0.0007
619 ILL-DEFINED DISORDER 43 0.0007
620 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
621 MYALGIA 120 0.0007
622 DEHYDRATION 94 0.0007
623 FACIAL PARALYSIS 6 0.0007
624 WEIGHT DECREASED 196 0.0007
625 BURNING SENSATION 49 0.0007
626 PAIN 429 0.0007
627 MOOD ALTERED 19 0.0007
628 JOINT SWELLING 84 0.0007
629 CARDIAC MURMUR 6 0.0007
630 ROAD TRAFFIC ACCIDENT 29 0.0007
631 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
632 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
633 SCIATICA 11 0.0007
634 HYPOAESTHESIA 103 0.0007
635 PROCEDURAL PAIN 19 0.0007
636 CONSTIPATION 149 0.0007
637 IRRITABILITY 41 0.0007
638 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
639 PRODUCT COMMUNICATION ISSUE 6 0.0007
640 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
641 COVID-19 PNEUMONIA 8 0.0007
642 VENTRICULAR EXTRASYSTOLES 7 0.0007
643 GAIT DISTURBANCE 129 0.0007
644 DRUG INEFFECTIVE 886 0.0007
645 ANAL INCONTINENCE 6 0.0007
646 BONE LOSS 10 0.0007
647 SKIN EXFOLIATION 56 0.0007
648 SCRATCH 7 0.0007
649 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
650 CARDIAC DISORDER 62 0.0007
651 JOINT DISLOCATION 7 0.0007
652 LIP SWELLING 22 0.0007
653 CORONARY ARTERY DISEASE 20 0.0007
654 CRYING 24 0.0007
655 COAGULOPATHY 11 0.0007
656 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
657 BLOOD COUNT ABNORMAL 10 0.0007
658 SKIN ULCER 17 0.0007
659 ALOPECIA 129 0.0007
660 RASH GENERALISED 17 0.0007
661 INFLUENZA LIKE ILLNESS 54 0.0007
662 PERIPHERAL COLDNESS 9 0.0007
663 INJECTION SITE REACTION 45 0.0007
664 FEELING HOT 40 0.0007
665 CARDIOMEGALY 8 0.0006
666 PERICARDIAL EFFUSION 15 0.0006
667 PARAESTHESIA 102 0.0006
668 JOINT STIFFNESS 17 0.0006
669 INJECTION SITE ERYTHEMA 80 0.0006
670 HYPERHIDROSIS 83 0.0006
671 HEPATIC STEATOSIS 12 0.0006
672 BIPOLAR DISORDER 7 0.0006
673 THERAPY CESSATION 33 0.0006
674 URINARY INCONTINENCE 19 0.0006
675 PLEURAL EFFUSION 39 0.0006
676 FLANK PAIN 6 0.0006
677 DEVICE OCCLUSION 9 0.0006
678 SKIN REACTION 9 0.0006
679 AFFECTIVE DISORDER 5 0.0006
680 SUICIDAL IDEATION 58 0.0006
681 NAUSEA 499 0.0006
682 RASH MACULAR 22 0.0006
683 ULCER 10 0.0006
684 CYSTITIS 20 0.0006
685 RASH ERYTHEMATOUS 30 0.0006
686 INJECTION SITE PRURITUS 42 0.0006
687 STOMATITIS 38 0.0006
688 INJECTION SITE PAIN 192 0.0006
689 ACCIDENTAL UNDERDOSE 9 0.0006
690 HOT FLUSH 47 0.0006
691 ERUCTATION 12 0.0006
692 FLUSHING 63 0.0006
693 SYNCOPE 62 0.0006
694 DEVICE DIFFICULT TO USE 41 0.0006
695 SEPSIS 69 0.0006
696 DEEP VEIN THROMBOSIS 40 0.0006
697 INJECTION SITE BRUISING 49 0.0006
698 MICTURITION URGENCY 7 0.0006
699 MUSCULOSKELETAL PAIN 32 0.0006
700 WOUND 17 0.0006
701 DRY SKIN 81 0.0006
702 SARS-COV-2 TEST POSITIVE 8 0.0006
703 DEVICE USE ERROR 21 0.0006
704 ABDOMINAL DISTENSION 63 0.0006
705 ADVERSE REACTION 8 0.0006
706 PRESCRIBED UNDERDOSE 12 0.0006
707 SKIN DISORDER 20 0.0006
708 URINARY RETENTION 20 0.0006
709 BRAIN INJURY 6 0.0006
710 SOMNOLENCE 120 0.0006
711 INJECTION SITE MASS 22 0.0006
712 FEEDING DISORDER 12 0.0006
713 DEVICE ISSUE 53 0.0006
714 ABDOMINAL DISCOMFORT 98 0.0006
715 CORONARY ARTERY OCCLUSION 8 0.0006
716 UNRESPONSIVE TO STIMULI 15 0.0006
717 GASTROINTESTINAL DISORDER 52 0.0006
718 ASTHENIA 218 0.0006
719 HUNGER 8 0.0006
720 TRANSFUSION 6 0.0006
721 DEVICE USE ISSUE 10 0.0006
722 LOSS OF CONSCIOUSNESS 73 0.0006
723 PULMONARY EMBOLISM 54 0.0006
724 INCONTINENCE 6 0.0006
725 RENAL PAIN 6 0.0006
726 FLATULENCE 32 0.0006
727 MUSCLE TWITCHING 13 0.0006
728 BREAST PAIN 6 0.0006
729 DRUG DOSE OMISSION BY DEVICE 44 0.0006
730 SKIN CANCER 12 0.0006
731 GASTRIC DISORDER 19 0.0006
732 AMNESIA 36 0.0006
733 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
734 NEUROPATHY PERIPHERAL 52 0.0005
735 PYREXIA 189 0.0005
736 RHEUMATOID ARTHRITIS 62 0.0005
737 PHOTOSENSITIVITY REACTION 9 0.0005
738 PRODUCT ADMINISTRATION ERROR 11 0.0005
739 BALANCE DISORDER 47 0.0005
740 ABNORMAL DREAMS 15 0.0005
741 TASTE DISORDER 11 0.0005
742 HYPOKALAEMIA 25 0.0005
743 HEART RATE DECREASED 19 0.0005
744 DIARRHOEA 349 0.0005
745 LETHARGY 31 0.0005
746 FEELING COLD 15 0.0005
747 PRODUCT SUBSTITUTION ISSUE 31 0.0005
748 COLON CANCER 8 0.0005
749 NODULE 7 0.0005
750 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
751 THERAPY NON-RESPONDER 24 0.0005
752 BLOOD CALCIUM DECREASED 6 0.0005
753 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
754 HYPOTHYROIDISM 17 0.0005
755 ARTERIOSCLEROSIS 5 0.0005
756 ANKYLOSING SPONDYLITIS 7 0.0005
757 MITRAL VALVE INCOMPETENCE 6 0.0005
758 BONE PAIN 31 0.0005
759 HIP FRACTURE 17 0.0005
760 HYPOCALCAEMIA 10 0.0005
761 FRACTURE 10 0.0005
762 RED BLOOD CELL COUNT DECREASED 15 0.0005
763 ADVERSE DRUG REACTION 47 0.0005
764 HIP ARTHROPLASTY 8 0.0005
765 VOMITING 245 0.0005
766 LYMPHOMA 8 0.0005
767 PRESCRIBED OVERDOSE 10 0.0005
768 BLINDNESS 21 0.0005
769 RENAL DISORDER 24 0.0005
770 SPLENOMEGALY 6 0.0005
771 VISUAL ACUITY REDUCED 17 0.0005
772 COELIAC DISEASE 5 0.0005
773 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
774 SICKLE CELL ANAEMIA WITH CRISIS 8 0.0005
775 SEPTIC SHOCK 22 0.0005
776 MENTAL DISORDER 22 0.0005
777 ARTHROPATHY 28 0.0005
778 MACULAR DEGENERATION 6 0.0005
779 ERYTHEMA 103 0.0005
780 MASS 7 0.0005
781 BLOOD GLUCOSE DECREASED 24 0.0005
782 PREGNANCY 10 0.0005
783 THYROID CANCER 6 0.0005
784 HYPOTENSION 100 0.0005
785 APHASIA 15 0.0005
786 BLINDNESS UNILATERAL 7 0.0005
787 PELVIC PAIN 9 0.0005
788 SINUS TACHYCARDIA 7 0.0005
789 PSORIATIC ARTHROPATHY 20 0.0005
790 MUSCLE SPASTICITY 6 0.0005
791 OFF LABEL USE 427 0.0005
792 SMALL INTESTINAL OBSTRUCTION 6 0.0005
793 MULTIPLE FRACTURES 8 0.0005
794 INJECTION SITE WARMTH 10 0.0005
795 TENDON RUPTURE 6 0.0005
796 DIABETES MELLITUS 37 0.0005
797 LIMB DISCOMFORT 15 0.0005
798 VENTRICULAR TACHYCARDIA 8 0.0005
799 DEVICE LEAKAGE 21 0.0005
800 DISEASE RECURRENCE 23 0.0005
801 FEAR 13 0.0005
802 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
803 HYPOKINESIA 7 0.0005
804 FREQUENT BOWEL MOVEMENTS 13 0.0005
805 FLUID OVERLOAD 7 0.0005
806 PNEUMONIA ASPIRATION 12 0.0005
807 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
808 CARDIOMYOPATHY 7 0.0005
809 GASTRIC ULCER 9 0.0005
810 ABDOMINAL PAIN 110 0.0005
811 INTRAOCULAR PRESSURE INCREASED 6 0.0005
812 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
813 MOVEMENT DISORDER 15 0.0005
814 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
815 ANAPHYLACTIC SHOCK 12 0.0005
816 DYSTONIA 9 0.0005
817 HAEMATOMA 12 0.0005
818 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
819 CARDIAC FAILURE 37 0.0005
820 DECREASED APPETITE 107 0.0005
821 DEAFNESS 12 0.0005
822 CHOLELITHIASIS 15 0.0005
823 MUSCULOSKELETAL STIFFNESS 40 0.0005
824 BEDRIDDEN 6 0.0005
825 DEVICE RELATED INFECTION 7 0.0005
826 HAEMATOCHEZIA 25 0.0005
827 DYSMENORRHOEA 6 0.0005
828 PRESYNCOPE 11 0.0005
829 ANGIOEDEMA 20 0.0005
830 FEMUR FRACTURE 14 0.0005
831 PSORIASIS 59 0.0005
832 DYSARTHRIA 17 0.0005
833 JOINT RANGE OF MOTION DECREASED 6 0.0004
834 BRAIN FOG 7 0.0004
835 MOBILITY DECREASED 32 0.0004
836 BLISTER 25 0.0004
837 CHROMATURIA 10 0.0004
838 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
839 BODY TEMPERATURE INCREASED 9 0.0004
840 PNEUMONITIS 12 0.0004
841 DEVICE MECHANICAL ISSUE 6 0.0004
842 RESTLESSNESS 16 0.0004
843 SKIN IRRITATION 20 0.0004
844 HAEMATEMESIS 11 0.0004
845 MENTAL STATUS CHANGES 12 0.0004
846 ABNORMAL BEHAVIOUR 17 0.0004
847 MOUTH ULCERATION 9 0.0004
848 BLOOD SODIUM DECREASED 8 0.0004
849 PULMONARY OEDEMA 19 0.0004
850 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
851 ARRHYTHMIA 20 0.0004
852 AGITATION 31 0.0004
853 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
854 EMOTIONAL DISORDER 13 0.0004
855 BLOOD URINE PRESENT 8 0.0004
856 RECTAL HAEMORRHAGE 18 0.0004
857 MYOCARDIAL INFARCTION 73 0.0004
858 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
859 BLOOD PRESSURE FLUCTUATION 10 0.0004
860 POST PROCEDURAL COMPLICATION 8 0.0004
861 PANCREATIC CARCINOMA 12 0.0004
862 FAECES DISCOLOURED 9 0.0004
863 EMOTIONAL DISTRESS 50 0.0004
864 INJURY 29 0.0004
865 MENTAL IMPAIRMENT 10 0.0004
866 HAEMATURIA 14 0.0004
867 DISTURBANCE IN ATTENTION 22 0.0004
868 ACUTE MYOCARDIAL INFARCTION 12 0.0004
869 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
870 LABORATORY TEST ABNORMAL 12 0.0004
871 PARANOIA 7 0.0004
872 CEREBROVASCULAR ACCIDENT 68 0.0004
873 INJECTION SITE HAEMORRHAGE 32 0.0004
874 INTESTINAL OBSTRUCTION 15 0.0004
875 ACCIDENTAL EXPOSURE TO PRODUCT 41 0.0004
876 FULL BLOOD COUNT DECREASED 8 0.0004
877 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
878 ANAEMIA 75 0.0004
879 INFLAMMATION 20 0.0004
880 LEUKOCYTOSIS 7 0.0004
881 COGNITIVE DISORDER 18 0.0004
882 BASAL CELL CARCINOMA 6 0.0004
883 ANGINA PECTORIS 11 0.0004
884 BLOOD GLUCOSE INCREASED 72 0.0004
885 PANCREATITIS 20 0.0004
886 HALLUCINATION, AUDITORY 6 0.0004
887 BRADYCARDIA 20 0.0004
888 DYSSTASIA 11 0.0004
889 MULTIPLE SCLEROSIS 18 0.0004
890 NEOPLASM MALIGNANT 25 0.0004
891 ASCITES 11 0.0004
892 SENSORY DISTURBANCE 6 0.0004
893 DRUG INTOLERANCE 36 0.0004
894 HEPATIC CIRRHOSIS 7 0.0004
895 PROTEINURIA 7 0.0004
896 MUSCULOSKELETAL DISORDER 7 0.0004
897 IMPAIRED HEALING 12 0.0004
898 MANIA 6 0.0004
899 ABASIA 9 0.0004
900 PRODUCT ADHESION ISSUE 13 0.0004
901 CARDIAC ARREST 30 0.0004
902 AGGRESSION 18 0.0004
903 BLOOD UREA INCREASED 6 0.0004
904 HALLUCINATION 27 0.0004
905 WITHDRAWAL SYNDROME 15 0.0004
906 BLOOD TEST ABNORMAL 5 0.0004
907 DEVICE DISLOCATION 15 0.0003
908 HAEMORRHAGE 36 0.0003
909 NEEDLE ISSUE 10 0.0003
910 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
911 SEIZURE 39 0.0003
912 PAIN OF SKIN 9 0.0003
913 HAEMOGLOBIN DECREASED 34 0.0003
914 BONE DISORDER 6 0.0003
915 SKIN LESION 9 0.0003
916 DISORIENTATION 13 0.0003
917 OVERDOSE 70 0.0003
918 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
919 HEPATIC ENZYME INCREASED 22 0.0003
920 THERAPY INTERRUPTED 23 0.0003
921 BLOOD CREATININE INCREASED 21 0.0003
922 RENAL IMPAIRMENT 27 0.0003
923 COLITIS 12 0.0003
924 CONFUSIONAL STATE 51 0.0003
925 COLITIS ULCERATIVE 14 0.0003
926 HYPOPHAGIA 8 0.0003
927 ERECTILE DYSFUNCTION 8 0.0003
928 APPLICATION SITE PRURITUS 7 0.0003
929 MENORRHAGIA 6 0.0003
930 HAEMATOCRIT DECREASED 6 0.0003
931 BREAST CANCER FEMALE 8 0.0003
932 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
933 DEVICE BREAKAGE 12 0.0003
934 DYSKINESIA 12 0.0003
935 ACNE 22 0.0003
936 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
937 ACCIDENTAL OVERDOSE 10 0.0003
938 SEDATION 7 0.0003
939 PRODUCT STORAGE ERROR 23 0.0003
940 DEATH 226 0.0003
941 BLOOD BILIRUBIN INCREASED 7 0.0003
942 RESPIRATORY ARREST 7 0.0003
943 SKIN BURNING SENSATION 18 0.0003
944 DEMENTIA 7 0.0003
945 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
946 HYPONATRAEMIA 14 0.0002
947 C-REACTIVE PROTEIN INCREASED 9 0.0002
948 CEREBRAL INFARCTION 6 0.0002
949 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
950 EXPOSURE DURING PREGNANCY 15 0.0002
951 LIVER FUNCTION TEST ABNORMAL 7 0.0002
952 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
953 PLATELET COUNT DECREASED 25 0.0002
954 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
955 TREATMENT FAILURE 19 0.0002
956 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
957 APPLICATION SITE PAIN 5 0.0002
958 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
959 MENSTRUATION IRREGULAR 6 0.0002
960 PALLOR 6 0.0002
961 HYPERGLYCAEMIA 8 0.0002
962 METABOLIC ACIDOSIS 7 0.0002
963 CARDIO-RESPIRATORY ARREST 9 0.0002
964 DRUG INTERACTION 34 0.0002
965 OSTEONECROSIS 7 0.0002
966 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
967 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
968 HYPOGLYCAEMIA 10 0.0002
969 PLASMA CELL MYELOMA 8 0.0002
970 BREAST CANCER 19 0.0002
971 ABDOMINAL PAIN LOWER 5 0.0002
972 CONVULSION 11 0.0002
973 COMA 9 0.0002
974 LACTIC ACIDOSIS 6 0.0002
975 VAGINAL HAEMORRHAGE 8 0.0002
976 LIVER DISORDER 8 0.0002
977 ABORTION SPONTANEOUS 7 0.0002
978 DELIRIUM 6 0.0002
979 INTENTIONAL OVERDOSE 11 0.0002
980 DISEASE PROGRESSION 20 0.0002
981 INTERSTITIAL LUNG DISEASE 8 0.0002
982 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
983 NEUTROPHIL COUNT DECREASED 6 0.0001
984 CEREBRAL HAEMORRHAGE 5 0.0001
985 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
986 SUICIDE ATTEMPT 7 0.0001
987 PANCYTOPENIA 6 0.0001
988 THROMBOCYTOPENIA 10 0.0001
989 TOXICITY TO VARIOUS AGENTS 14 0.0001
990 DRUG WITHDRAWAL SYNDROME 7 0.0001
991 PROSTATE CANCER 6 0.0001